| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |